Variant report
Variant | nsv963606 |
---|---|
Chromosome Location | chr4:69256970-69259014 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370266009 | chr4:69256989-69256990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540920913 | chr4:69257029-69257030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187148052 | chr4:69257038-69257039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368557117 | chr4:69257064-69257065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144043083 | chr4:69257120-69257121 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542625099 | chr4:69257197-69257198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562612782 | chr4:69257214-69257215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531835444 | chr4:69257261-69257262 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551247157 | chr4:69257281-69257282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377031159 | chr4:69257289-69257290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533835892 | chr4:69257326-69257327 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1919901 | chr4:69257421-69257422 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs1919902 | chr4:69257453-69257454 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs191996889 | chr4:69257470-69257471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536521808 | chr4:69257492-69257493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183039950 | chr4:69257586-69257587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376872184 | chr4:69257638-69257639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536226077 | chr4:69257651-69257652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556200558 | chr4:69257668-69257669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569613471 | chr4:69257685-69257686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538718844 | chr4:69257686-69257687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558416683 | chr4:69257772-69257773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150159485 | chr4:69257863-69257864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188726226 | chr4:69257890-69257891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193261085 | chr4:69257977-69257978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574013894 | chr4:69257980-69257981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575965769 | chr4:69257984-69257985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542565470 | chr4:69258019-69258020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562552077 | chr4:69258046-69258047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145653971 | chr4:69258087-69258088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541614787 | chr4:69258110-69258111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545479792 | chr4:69258140-69258141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368151297 | chr4:69258177-69258178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527448180 | chr4:69258190-69258191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184117048 | chr4:69258201-69258202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561119995 | chr4:69258230-69258231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550843212 | chr4:69258248-69258249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189527810 | chr4:69258257-69258258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541476379 | chr4:69258298-69258299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550142645 | chr4:69258325-69258326 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75280783 | chr4:69258344-69258345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191569839 | chr4:69258379-69258380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552231680 | chr4:69258492-69258493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146994652 | chr4:69258504-69258505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71598068 | chr4:69258509-69258510 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs370395766 | chr4:69258583-69258584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374071573 | chr4:69258616-69258617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529929611 | chr4:69258666-69258667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553945602 | chr4:69258667-69258668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376213940 | chr4:69258746-69258747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Oral cancer | 21386901 | CNVD |
Alcoholism | 21790672 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Schizophrenia | 20967226 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69253400-69258000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:69254000-69257400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr4:69254200-69257400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr4:69254200-69257400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr4:69254600-69258600 | Enhancers | Fetal Lung | lung |
6 | chr4:69255200-69258200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr4:69255600-69260600 | Weak transcription | Fetal Intestine Small | intestine |
8 | chr4:69255800-69257400 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr4:69255800-69270200 | Weak transcription | H9 Cell Line | embryonic stem cell |
10 | chr4:69256200-69260200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr4:69256400-69261600 | Weak transcription | Fetal Intestine Large | intestine |
12 | chr4:69256600-69257400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr4:69256600-69257400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr4:69256600-69260000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr4:69257400-69263800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
16 | chr4:69257400-69272000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr4:69258000-69269200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |